Literature DB >> 2078922

Oxidative state of glutathione in red blood cells and plasma of diabetic patients: in vivo and in vitro study.

C Costagliola1.   

Abstract

The oxidative state of glutathione in red blood cells (RBC) and plasma of diabetic patients and of age-matched volunteers has been studied. Oxidized glutathione (GSSG) levels in plasma from diabetic subjects were higher than those from controls (17.2 +/- 2.5 and 3.3 +/- 0.4 micrograms/ml, respectively). This phenomenon was evident also in in vitro experiments: incubated RBC from diabetic patients released very high amounts of GSSG in medium. Thus, erythrocytes are responsible for the enhanced amounts of GSSG found in plasma from diabetic patients. The fall in the conversion of GSSG to reduced glutathione in RBC could be due to a reduced activity of the glucose-6-phosphate dehydrogenase (G6PDH) enzyme which has been observed in diabetic patients. In this way, G6PDH supplies reduced amounts of NADPH to the glutathione reductase enzyme affecting the integrity of the glutathione system; on the other hand, the activation by glucose of the polyol pathway also reduces the levels of NADPH for the glutathione reductase enzyme.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2078922

Source DB:  PubMed          Journal:  Clin Physiol Biochem        ISSN: 0252-1164


  12 in total

1.  Electrophoretic separations in poly(dimethylsiloxane) microchips using a mixture of ionic and zwitterionic surfactants.

Authors:  Qian Guan; Scott D Noblitt; Charles S Henry
Journal:  Electrophoresis       Date:  2012-01       Impact factor: 3.535

2.  Selective detection of endogenous thiols using microchip-based flow analysis and mercury/gold amalgam microelectrodes.

Authors:  Nicholas G Batz; R Scott Martin
Journal:  Analyst       Date:  2008-10-29       Impact factor: 4.616

Review 3.  Drug-induced methaemoglobinaemia. Treatment issues.

Authors:  M D Coleman; N A Coleman
Journal:  Drug Saf       Date:  1996-06       Impact factor: 5.606

4.  A microfluidic technique for monitoring bloodstream analytes indicative of C-peptide resistance in type 2 diabetes.

Authors:  Teresa D'Amico Oblak; Jennifer A Meyer; Dana M Spence
Journal:  Analyst       Date:  2008-11-27       Impact factor: 4.616

5.  The erythrocyte glutathione levels during oral glucose tolerance test.

Authors:  D Konukoğlu; H Hatemi; E M Ozer; S Gönen; T Akçay
Journal:  J Endocrinol Invest       Date:  1997-09       Impact factor: 4.256

6.  Simultaneous determination of cell aging and ATP release from erythrocytes and its implications in type 2 diabetes.

Authors:  Wasanthi Subasinghe; Dana M Spence
Journal:  Anal Chim Acta       Date:  2008-05-04       Impact factor: 6.558

7.  Personalized metabolic assessment of erythrocytes using microfluidic delivery to an array of luminescent wells.

Authors:  Nicole V Tolan; Luiza I Genes; Wasanthi Subasinghe; Madushi Raththagala; Dana M Spence
Journal:  Anal Chem       Date:  2009-04-15       Impact factor: 6.986

Review 8.  Diabetic Retinopathy: Vascular and Inflammatory Disease.

Authors:  F Semeraro; A Cancarini; R dell'Omo; S Rezzola; M R Romano; C Costagliola
Journal:  J Diabetes Res       Date:  2015-06-07       Impact factor: 4.011

9.  Increasing glucose 6-phosphate dehydrogenase activity restores redox balance in vascular endothelial cells exposed to high glucose.

Authors:  Zhaoyun Zhang; Zhihong Yang; Bo Zhu; Ji Hu; Chong Wee Liew; Yingyi Zhang; Jane A Leopold; Diane E Handy; Joseph Loscalzo; Robert C Stanton
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

10.  Soluble receptor for advanced glycation end-product (sRAGE)/pentosidine ratio: a potential risk factor determinant for type 2 diabetic retinopathy.

Authors:  Zhi Xiang Ng; Kek Heng Chua; Tajunisah Iqbal; Umah Rani Kuppusamy
Journal:  Int J Mol Sci       Date:  2013-04-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.